P D Zenobi

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.

P D Zenobi, S. E. Jaeggi-Groisman, Walter F. Riesen et al. · Journal of Clinical Investigation · 1992 · 146 citations · Full text

Insulin Resistance, Nutrition, Metabolic Syndrome +14

Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.

P D Zenobi, Sahara Graf, Heinrich W. Ursprung et al. · Journal of Clinical Investigation · 1992 · 137 citations · Full text

Insulin Resistance, Metabolic Syndrome, Nutrition +15

Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance

P D Zenobi, T. Torresani, E A Werder et al. · Diabetologia · 1991 · 114 citations · Full text

Insulin Resistance, Metabolic Syndrome, Diabetes Management +10

Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I

P D Zenobi, P. Holzmann, Yvonne Glatz et al. · Diabetologia · 1993 · 50 citations · Full text

Obesity, Metabolic Syndrome, Body Composition +10

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A

P D Zenobi, Yvonne Glatz, Annamarie Keller et al. · European Journal of Endocrinology · 1994 · 47 citations